UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to determine if tunneling standard short-term central lines for a short distance under the skin, with the assistance of ultrasound imaging, reduces the risk of central line infections for catheters placed in the neck vein.
Previous work has shown that these lines can be tunneled without ultrasound guidance. We wish to determine if the use of ultrasound makes the tunneling procedure safer and easier.
| Condition | Intervention |
|---|---|
|
Infection Bacteremia |
Procedure: To tunnel Procedure: Standard (not to tunnel) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | UGIST Pilot Trial: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling. Does it Reduce the Technical Difficulty and Mechanical Complications? |
- Reduction in Technical difficulty [ Time Frame: 6-8 weeks for the whole 20 pts. ] [ Designated as safety issue: Yes ]
- Signs of line related blood stream infection/bacteremia. [ Time Frame: 6-8 weeks for all 20 pts. ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 20 |
| Study Start Date: | March 2008 |
| Estimated Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1
To Tunnel
|
Procedure: To tunnel
Using the standard Seldinger technique and under the guidance of ultrasound, the catheter will pass through a 3-5cm subcutaneous tunnel before it is eventually secured to reside at the internal jugular vein.
|
|
Active Comparator: 2
Not to tunnel
|
Procedure: Standard (not to tunnel)
Using the standard Seldinger technique and under the guidance of ultrasound, the catheter is secured to reside at the internal jugular vein, without a subcutaneous tunnel.
|
Detailed Description:
More than 250,000 vascular catheter-related bloodstream infections occur annually in the USA with a mortality ranging from 12% to 25% in critically ill patients.
It is also widely accepted that the internal jugular site is associated with a higher risk of catheter related infection if compared with the subclavian site.
Therefore, the benefit of catheter tunneling was best seen at the internal jugular site as described by J F Timsit in 1996 in his prospective randomized multicentre study where it significantly decreased the rate of catheter related sepsis from 11.4% to 3.4%.
At the same time, tunneling catheters did not increase the rate of mechanical complications such as pneumothorax, hematoma, or arterial puncture, but it almost doubled the rate of technical difficulties, such as problems with advancing the catheter or multiple puncture sites, at that time it was a blind technique.
Now, and with the introduction of the ultrasound guidance in our routine central line insertions, we would like to evaluate its benefit in reducing the technical difficulty and mechanical complications that used to be encountered while tunneling the short term central venous catheters at the internal jugular site.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult ICU patients.
- Likely to need the line for 48 hours.
- Standard central venous catheter.
Exclusion Criteria:
- Mechanical impedance (e.g C-spine protection).
- Absent Internal jugular vessel on U/S.
- Previous line still in place.
- Presence of overlying skin or tissue infection or mass.
- Tricuspid valve vegetation.
- Tumor extending to the right atrium.
- Persistent coagulopathy.
- Newly inserted Pacemaker leads.
- Recent carotid endarterectomy on same side.
- No ultrasound facility available.
- Patients requiring special lines (e.g. Dialysis).
Contacts and Locations| Contact: Salah A Taqi, MBChB | 905-521-2100 ext 75170 | sataqi@hotmail.com |
| Contact: Corey Sawchuk, MD | 905-527-4322 ext 46698 | ctw_sawchuk@yahoo.com |
| Canada, Ontario | |
| Hamilton Health Sciences Corporation | Recruiting |
| Hamilton, Ontario, Canada, L8L 2X2 | |
| Principal Investigator: Central investigators | |
| Principal Investigator: | Salah A Taqi, MBChB | McMaster Health Sciences |
More Information
No publications provided
| Responsible Party: | SALAH ALI TAQI, McMaster University |
| ClinicalTrials.gov Identifier: | NCT00639197 History of Changes |
| Other Study ID Numbers: | 08-007 |
| Study First Received: | March 11, 2008 |
| Last Updated: | April 10, 2008 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by McMaster University:
|
Tunneling Short term central venous catheters |
Ultrasound Guided Internal jugular Assess safety and improve technical difficulty |
Additional relevant MeSH terms:
|
Bacteremia Bacterial Infections Sepsis Infection |
Systemic Inflammatory Response Syndrome Inflammation Pathologic Processes |
ClinicalTrials.gov processed this record on May 19, 2013